Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 14   

Articles published

NYMX 4.28 -0.47 (-9.89%)
price chart
Trader's Alert - Activision Blizzard, Inc. (NASDAQ:ATVI), Nymox Pharmaceutical ...
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) shares rose Wednesday, after the pharmaceutical company released positive outcome results from its ongoing prospective NX03-0040 trial of NX-1207 for the treatment of low grade localized prostate ...
Related articles »  
Encouraging trial results for Nymox prostate cancer drug candidate (NYMX)
In an analysis of clinical outcomes at eight months in a 146-patient Phase 2 clinical trial evaluating the safety and efficacy of Nymox's (NYMX +3.9%) drug candidate for low grade localized prostate cancer, NX-1207, the proportion of patients who ...
Nymox Pharma (NYMX) Reports Positive Prostate Cancer Trial Results  StreetInsider.com (subscription)
Nymox Pharma Reports Positive Prostate Cancer 8 Month Clinical Trial Results  RTT News
Related articles »  
Whats Hot Today : Taiwan Semiconductor Manufacturing Company Limited ...
On August 11, Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced its financial results for the second quarter of 2014.
Traders Are Watching: AK Steel Holding (NYSE:AKS), Glimcher Realty Trust ...
Nymox Pharma Corporation (Nasdaq:NYMX) announced new positive outcome results from the Company's ongoing prospective NX03-0040 trial of NX-1207 for the treatment of low grade localized prostate cancer.
Related articles »  
Why Making Dramatic Moves : Xerox Corporation (NYSE:XRX), PharMerica ...
On 11 AUG Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced its financial results for the second quarter of 2014. Nymox reported net losses of $820,272, or $0.02 per share, for the quarter and $3,413,088, or $0.10 per share, for the six months ...
Related articles »  
Active Watch List : Cisco Systems (NASDAQ:CSCO), Aeropostale (NYSE:ARO ...
Aeropostale, Inc. (NYSE:ARO) price to sales (P/S) ratio is 0.15. On AUG 11, Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced its financial results for the second quarter of 2014.
5 Stocks Under Wall Street's Radar : BP (NYSE:BP), Semiconductor ...
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced positive efficacy data from its phase III NX02-022 repeat injection study of NX-1207 for BPH.